Press Release – New York, NY – February 17, 2022 – Sichenzia Ross Ference LLP today announced that it represented Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company focused on the …
Sichenzia Ross Ference LLP Represents Alliance Global Partners as Financial Advisor in a $5.9 Million Warrant Exercise for ShiftPixy, Inc.
Press Release – New York, NY – January 31, 2022 – Sichenzia Ross Ference LLP today announced that it represented Alliance Global Partners (AGP), as the financial advisor for the warrant exercise for …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd.
Press Release – New York, NY – December 30, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of BiondVax …
Sichenzia Ross Ference LLP Represents Zynex, Inc. in its $31.0 Million Acquisition of Kestrel Labs
Press Release – New York, NY – December 23, 2021 – Sichenzia Ross Ference LLP announced today that its mergers and acquisitions team represented Zynex, Inc. (NASDAQ ZYXI) in its acquisition of Kestrel …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $25 Million Initial Public Offering for Cingulate, Inc.
Press Release – New York, NY – December 13, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an initial public offering of Cingulate …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $77 Million Public Offering for Nisun International
Press Release – New York, NY – December 16, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Nisun …
